Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of FT-7051 in Men With Metastatic Castration-Resistant Prostate Cancer

NCT04575766 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT04575766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04575766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of FT-7051 in Men With Metastatic Castration-Resistant Prostate Cancer
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Terminated
Start date
December 30, 2020
Completion date
November 15, 2022
Enrollment
25 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer